Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

BMC Medicine volume 18, Article number: 29 (2020) Cite this article

Correction to: BMC Med (2012) 10:28

https://doi.org/10.1186/1741-7015-10-28

Following publication of the original article [1], the authors reported that there was an error in Fig. 9, which contained a misplaced picture. The authors confirm that all of the published results and conclusions of the paper remain unchanged, as well as the figure legends. The authors apologize for any confusion caused. The corrected Fig. 9 is shown as follows:

Fig. 9
figure1

Effect of combination of EGFR siRNA and afatinib with Hoechst 33342 and PI double fluorescent staining. Effect of the combination of an EGFR siRNA and afatinib detected by Hoechst 33342 and PI double fluorescent staining. The concentrations were afatinib: 0.01 nM (assayed 72 h post treatment) and EGFR siRNA: 200 nM (assayed 48 h post transfection). Similar results were found with other concentrations of afatinib, and other drugs in all the five cell lines (data not shown).

Full size image

Reference

  1. 1.

    Chen G, Kronenberger P, Teugels E, Umelo IA, De Grève J. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Med. 2012;10:28. https://doi.org/10.1186/1741-7015-10-28 PubMed PMID: 22436374; PubMed Central PMCID: PMC3334713.

Download references

Author information

Affiliations

  1. Laboratory of Medical and Molecular Oncology and Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium
    • Gang Chen
    • , Peter Kronenberger
    • , Erik Teugels
    • , Ijeoma Adaku Umelo
    •  & Jacques De Grève
  2. Department of Pathology, First Affiliated Hospital, Guangxi Medical University, Shuangyong Road 6, 530021, Nanning, Guangxi, People’s Republic of China
    • Gang Chen
  3. Department of Gezondheidszorg, Erasmushogeschool Brussel, Laboratory for Biotechnology, Laarbeeklaan 125, 1090, Brussels, Belgium
    • Peter Kronenberger
Authors
  1. Search for Gang Chen in:
  2. Search for Peter Kronenberger in:
  3. Search for Erik Teugels in:
  4. Search for Ijeoma Adaku Umelo in:
  5. Search for Jacques De Grève in:

Corresponding author

Correspondence to Jacques De Grève.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chen, G., Kronenberger, P., Teugels, E. et al. Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Med 18, 29 (2020). https://doi.org/10.1186/s12916-020-1501-8

Download citation

BMC Medicine

ISSN: 1741-7015

Contact us